GlaxoSmithKline Consumer Nigeria Plc Stock Price

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over the counter (OTC) medicines, and nutritional healthcare products. The Pharmaceuticals segment provides antibacterial, vaccines, and prescription drugs. It provides pain relief medicine under the Panadol and Voltaren brands; digestive health products under the brand Andrews Liver Salts; oral health products under the Macleans and Sensodyne brands; and respiratory medicine under the Panadol Cold & Catarrh and Otrivin brands. The company was formerly known as Beecham Limited and changed its name to GlaxoSmithKline Consumer Nigeria Plc. GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971 and is headquartered in Lagos, Nigeria.